🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Genomics BioSci & Tech. Co.,Ltd. (TPE:4195)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
11.70
-1.15 (-8.95%)
At close: Nov 20, 2026

Genomics BioSci & Tech. Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
740.73708.38517.58396.14419389.97
Revenue Growth
21.85%36.86%30.65%-5.46%7.45%-12.01%
Cost of Revenue
529.19477.02360.4276.23282.99280.04
Gross Profit
211.54231.36157.18119.91136.01109.92
Selling, General & Admin
244.86223.48207.53148.47131.79121.69
Research & Development
100.0582.588.556.4335.8817.47
Operating Expenses
347.44315.52297.47201.81169.53138.58
Operating Income
-135.9-84.16-140.29-81.9-33.52-28.66
Interest Expense
-15.24-13.7-7.74-4.74-1.98-1.67
Interest & Investment Income
1.852.112.372.090.350.27
Earnings From Equity Investments
---52.72-19.56-18.88-13.46
Currency Exchange Gain (Loss)
1.191.190.430.860.72-1.31
Other Non Operating Income (Expenses)
-12.04-1.1212.080.580.81.05
EBT Excluding Unusual Items
-160.13-95.68-185.87-102.67-52.5-43.78
Gain (Loss) on Sale of Investments
25.1425.14-47.06-65.29124.76-9.31
Gain (Loss) on Sale of Assets
2.892.89-1.06--65.18
Asset Writedown
---1.36---
Other Unusual Items
0.020.0200.02-0.01
Pretax Income
-132.08-67.63-235.35-167.9472.2612.09
Income Tax Expense
0.61--0.130.66-
Earnings From Continuing Operations
-132.7-67.63-235.35-168.0771.612.09
Net Income to Company
-132.7-67.63-235.35-168.0771.612.09
Minority Interest in Earnings
43.2928.212.25--6.65
Net Income
-89.41-39.43-223.1-168.0771.618.74
Net Income to Common
-89.41-39.43-223.1-168.0771.618.74
Net Income Growth
----282.09%2927.14%
Shares Outstanding (Basic)
757272716360
Shares Outstanding (Diluted)
757272716460
Shares Change
4.02%-1.89%11.87%5.12%0.23%
EPS (Basic)
-1.19-0.54-3.08-2.361.130.31
EPS (Diluted)
-1.19-0.54-3.08-2.361.130.31
EPS Growth
----267.48%3103.13%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-114.49-160.28-305.39-246.28-115.21-121.35
Free Cash Flow Per Share
-1.52-2.21-4.21-3.46-1.81-2.01
Dividend Per Share
----0.098-
Dividend Growth
------
Gross Margin
28.56%32.66%30.37%30.27%32.46%28.19%
Operating Margin
-18.35%-11.88%-27.11%-20.67%-8.00%-7.35%
Profit Margin
-12.07%-5.57%-43.10%-42.43%17.09%4.81%
Free Cash Flow Margin
-15.46%-22.63%-59.00%-62.17%-27.50%-31.12%
EBITDA
-63.87-20.73-85.84-49.01-5.410.81
EBITDA Margin
-8.62%-2.93%-16.59%-12.37%-1.29%0.21%
D&A For EBITDA
72.0363.4354.4532.8928.129.47
EBIT
-135.9-84.16-140.29-81.9-33.52-28.66
EBIT Margin
-18.35%-11.88%-27.11%-20.67%-8.00%-7.35%
Effective Tax Rate
----0.92%-